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Abstract
Objective: To investigate trends in obesity prevalence in recent years and to predict the obesity prevalence in 2015 in
European populations.
Methods: Data of 97 942 participants from seven cohorts involved in the European Prospective Investigation into Cancer
and Nutrition (EPIC) study participating in the Diogenes project (named as ‘‘Diogenes cohort’’ in the following) with weight
measurements at baseline and follow-up were used to predict future obesity prevalence with logistic linear and non-linear
(leveling off) regression models. In addition, linear and leveling off models were fitted to the EPIC-Potsdam dataset with five
weight measures during the observation period to find out which of these two models might provide the more realistic
prediction.
Results: During a mean follow-up period of 6 years, the obesity prevalence in the Diogenes cohort increased from 13% to
17%. The linear prediction model predicted an overall obesity prevalence of about 30% in 2015, whereas the leveling off
model predicted a prevalence of about 20%. In the EPIC-Potsdam cohort, the shape of obesity trend favors a leveling off
model among men (R
2=0.98), and a linear model among women (R
2=0.99).
Conclusion: Our data show an increase in obesity prevalence since the 1990ies, and predictions by 2015 suggests a sizeable
further increase in European populations. However, the estimates from the leveling off model were considerably lower.
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Introduction
Obesity (BMI $ 30 kg/m
2) is associated with a high risk of
chronic diseases such as diabetes, cardiovascular disease, certain
cancers and thus constitutes a major public health problem [1]. In
the past, the prevalence of obesity has been increasing rapidly in
Europe and all over the world and is estimated to increase further
[2,3,4]. However, the development of obesity differs across
countries [1,5] and across subpopulations within countries [6].
To achieve the most accurate prediction of future obesity
prevalence is a significant public health concern, especially for health
services and health economic reasons in the developed countries.
Previously, most researchers based their predictions on the
assumption that the trend is linear [7,8,9]. The assumption of a
linear trend of increase of the prevalence in obesity over a longer time
period in the future, however, could result in unrealistic scenarios.
Moreover, most studies on obesity trends are based on cross-
sectional survey data [2,10,11,12]. Cross-sectional data, however,
has the disadvantage that they only display the status at a certain
moment, but do not show the dynamics with respect to age, period
and birth cohort. Only data from longitudinal studies can address
such issues. Despite this, longitudinal data on obesity trends are
rarely found in the literature compared to cross-sectional data.
In view of the importance of understanding the dynamics of the
obesity epidemic, we used longitudinal data from five European
countries participating in the Diet, Obesity and Genes (DiOGenes)
[13] project to investigate the current state and observed time
trends of obesity prevalence. Furthermore, we aimed to predict the
prevalence in 2015 based on the observed trends assuming that the
trends observed in recent years will continue. The prediction
includes a linear and non-linear projection assuming a leveling off
of the obesity trend in the latter model. Both models were
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ments over time.
Materials and Methods
Study Populations
Diogenes cohort. The Diogenes cohort included participants
from five countries involved in the European Prospective
Investigation into Cancer and Nutrition (EPIC)-study, namely
Italy (Florence), the UK (Cambridge), The Netherlands
(Amsterdam-Maastricht and Doetinchem), Germany (Potsdam)
and Denmark (Aarhus and Copenhagen). The EPIC study has
been approved by each local ethics committee of all participating
study centers. The International Agency for research on Cancer
(IARC) ethics committee (IEC) gave its final vote based on all ethic
votes of the local ethic committees. Written informed consent for
measurements and inquiries including prospective data collection
has been obtained from all participants before joining EPIC.
Detailed information on the study population and data collection
of the EPIC study has been described elsewhere [14].
Between 1992 and 1998, 146 543 participants were recruited,
from which 102 346 (69.8%) took part in the follow-up
examination during 1998-2005. We excluded subjects with missing
dietary or follow-up data, women who were pregnant at baseline
or follow-up, subjects who were in the top and bottom 1% energy
intake/energy expenditure ratio, and those with implausible
anthropometric measures. Furthermore subjects with missing date
of recruitment were excluded; eventually 97 942 persons (41 456
men and 56 486 women) were available for the final analysis. Due
to differences in anthropometric measurements at follow-up and
length of follow-up time, participants from Doetinchem were
separated from those in Amsterdam and Maastricht; thus, a total
of seven cohorts were included in the present analysis.
EPIC-Potsdam. The EPIC- Potsdam cohort, which also
contributed to the Diogenes cohort, consists of 27 548 participants
from the general population of Potsdam, Germany, that were aged
mainly 35–65 years at recruitment (1994–1998) [15]. Every 2-3
years, updated information on body weight was available by
follow-up questionnaires [16,17]. Response rates for each follow-
up round exceeded 90%. Five measurements of weight during the
observation period were available for each participant. Subjects
with missing information for weight, height, or those who died or
dropped out during the follow-up period were excluded from this
study. In total, 22 229 participants (8 438 men and 13 791 women)
with information for weight at every follow-up assessment were
included into this study. Participants were followed until the 4
th
period of follow-up (2004–2008).
Anthropometric measurements
Data on body weight was collected at the baseline and follow-up
examinations. Height and weight were measured according to
centre-specific protocols. In Florence (I), Potsdam (D), Copenha-
gen and Aarhus (DK) weight was measured on participants in light
underwear to the nearest 0.1 kilograms whereas in Amsterdam-
Maastricht (NL), Doetinchem (NL) and Cambridge (UK)
participants were weighted to the nearest 0.1 kilograms in light
clothing after the removal of shoes. Details of the methods of
anthropometric measurement used at baseline have been de-
scribed previously [18]. At follow-up, body weight was directly
measured on participants in light clothing in the UK and
Doetinchem (NL), whereas in the other centers body weight was
assessed based on self-reports. In the Diogenes cohort, which refers
to a combined dataset of seven EPIC centers from five countries,
one follow-up measurements of weight was available for each
participant while in the single dataset of the EPIC-Potsdam cohort
four follow-up weight assessments were available.
Referring to body weight, corrections for differences in clothing
at baseline and follow-up as well as corrections for self-reporting at
follow-up were applied to consider differences in anthropometric
assessment among the centers and to increase comparability. To
correct for clothing, 1 kilogram was subtracted for weight if
participants were weighed in light clothing. Corrections for self-
reporting at follow-up were done using calibration methods
developed previously in the EPIC study [18].
BMI was calculated based on body weight and height (weight
(kg)/height (m)
2) and, according to current guidelines [1],
overweight and obesity were defined as a BMI of 25.0–29.9 kg/
m
2 and $ 30 kg/m
2, respectively.
Statistical Analysis
Development of obesity prevalence among the Diogenes
cohort. The magnitude of increase in obesity prevalence
between baseline and follow-up examinations was assessed by
comparing the prevalence of obesity (BMI $ 30 kg/m
2)a t
baseline with that at follow-up. All analyses were conducted
separately for men and women. Moreover, stratification due to
study centre and age group at baseline was applied to consider the
effect of age as well as differences between the single Diogenes sub-
cohorts.
Prediction of future obesity development among the
Diogenes cohort. The projections of obesity in the near
future were calculated based on the two kinds of logistic
regression models using individual weight change over time.
In the first model, probability of obesity was considered as
dependent variable, and follow-up time and age at recruitment as
independent variables. The second model was analogous to the
first, with the difference that the follow-up time variable was log-
transformed to simulate a non-linear (leveling off) trend in obesity
prevalence. All logistic regression analyses were stratified by sex
and centre, such that a set of sex- and centre-specific model
equations to predict the probability of obesity was derived.
By using these model equations, the probability of each
individual of becoming obese (above the threshold of BMI $
30 kg/m
2) at a certain point in time in the future was estimated.
The year 2015 was taken for this analysis which is in the near
future to avoid an extrapolation too far beyond the observation
period which is likely to result in an unrealistic prediction. The
individual values of follow-up time (from recruitment until 2015
(July, the 1
st)) and age at recruitment were inserted into the
respective model equation to extrapolate from the baseline
probability of being obese into the future. To estimate the
projected prevalence of obesity at the population level, the mean of
the individual values was taken.
Due to variation in age distribution between the Diogenes
centers, the analysis of trends in obesity prevalence was restricted
to the 40–65 y age groups - which in general existed in every sub-
sample- to increase comparability between centers. Thus, data
from 85 159 individuals were available for this analysis. The effect
of age was considered in two ways: 1) age at recruitment was
included as a covariate in the prediction models, and 2) trends in
obesity were stratified according to specific age groups (40–49, 50–
59 and 60–65 years) within the population of 40-65 year old
subjects.
Investigating the shape of obesity development in EPIC-
Potsdam. Additionally, the EPIC-Potsdam dataset was used to
investigate which of the two prediction models (linear and non-
linear; non-linear means that the increase in obesity is showing a
leveling off/saturation level) gives the better model fit. The EPIC-
Potsdam study comprises five repeated weight assessments per
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available in the other centers. For graphical illustration, the linear
and log function were fitted to the five data points (based on Least
Square Means) in a simple linear regression model and the
coefficients of determination (R
2) were calculated.
Furthermore, the observed prevalence and the estimated values
of logistic regression models for every follow-up period were
computed.
Results
Development of obesity prevalence in Diogenes
The Diogenes cohort had a mean age of 53.9 years (quartile
range: 50.5–59.7 years) and a mean BMI of 25.7 kg/m
2 (quartile
range: 23.0–27.8 kg/m
2) at baseline. The average follow-up time
was 6.4 years (quartile range 5.1–8.3 years). At baseline, 13% of 41
456 men and 13% of 56 486 women were obese, a further 50% of
men and 33% of women were overweight (BMI: 25–29.9 kg/m
2).
At follow-up, 17% were obese in men and in women, and 54% of
men and 37% of women were overweight.
In cross-sectional analyses, we observed a strong increase of
obesity prevalence with rising age, especially among women
between the age of 30 and 65 years (Figure 1 and Figure 2).
However, these curves differ between baseline and follow-up,
particularly for the 65–75 year age group. Whereas in the initial
baseline data lower prevalences could be observed among the 65–
75 year age group than in the younger age groups, the high level of
obesity prevalence at follow-up persisted even at this old age. The
positive relationship between age and obesity prevalence was also
observed in most of the individual centers, although the magnitude
of increase differed. The increase of obesity prevalence with rising
age was especially marked in Amsterdam-Maastricht, Florence
and Potsdam in both sexes as well as in Doetinchem and the
Danish centers among females (data not shown).
Besides an age effect, we also observed an effect of ‘birth cohort’
on obesity prevalence; i.e. subjects who were in the age group of
per example 60 years at recruitment, and shifted to the age group
of 65–70 years at follow-up, also showed an increase in obesity
prevalence during the follow-up period.
Finally, also when comparing persons of the same age at the
baseline and follow-up examination a slight increase in obesity
prevalence could be observed, which is more distinctive among
males compared to females (Figure 1 and Figure 2).
Obesity prevalence prediction for 2015 in Diogenes
The simple linear prediction model in 40-65 year old subjects
suggested an obesity prevalence of about 30% by year 2015
(range: 20.1–42.7%), whereas the leveling off model predicted an
obesity prevalence of about 20% (range: 15.5–27.3%) (Table 1).
The difference in predicted values from the linear vs. the leveling
off model was especially high in centers with a pronounced
increase in obesity prevalence during a comparatively short period
of follow-up (e.g. Cambridge and Doetinchem). For these centers,
extrapolation into the future was associated with a higher degree of
uncertainty compared to centers with longer follow-up. When
excluding Cambridge and Doetinchem the overall prevalence
estimates for 2015 did not change markedly which is due to the
relatively small sample size in these cohorts (data not shown).
In general, obesity prevalences at baseline and at follow-up were
higher in women than in men, except of Florence and the Danish
centers (Table 1).
According to the leveling off scenario, the highest prevalence for
2015 was predicted for men of the Potsdam cohort (27%), whereas
the lowest prevalence was estimated for women in the Danish
centers (16%). Hence, the estimated absolute increase of obesity
prevalence from baseline in the years 1995/1996 until 2015
ranged from 3% (Danish women) and 11% (Potsdam men).
Stratification according to age group at baseline revealed that
the increase in obesity prevalence is relatively independent of age,
Figure 1. Association of obesity prevalence and age among men of theDiogenes cohort. BMI values of individuals of the total Diogenes
cohort used for presenting obesity prevalence depending on the age (only prevalence estimates with at least 100 observations per age were
considered for the graph).
doi:10.1371/journal.pone.0027455.g001
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Diogenes cohort used for presenting obesity prevalence depending on the age (only prevalence estimates with at least 100 observations per age
were considered for the graph).
doi:10.1371/journal.pone.0027455.g002
Table 1. Prediction of obesity prevalence (BMI $ 30 kg/m
2) in the Diogenes centers
a.
n
Mean year of
baseline
measurement
Baseline
Obesity [%]
Mean Follow-
Up time (in
years)
Follow Up
Obesity [%]
b
Prediction 2015:
Obesity [%]
Absolute difference
between linear and
leveling off model in
%
d
Linear
model
c
Leveling off
model
c
Men
Potsdam (D) 6 690 1996 16.0 8.6 24.2 36.8 27.3 9.5
Florence (I) 2 048 1995 12.1 9.4 18.3 26.0 20.3 5.7
Cambridge (UK) 4 278 1995 9.2 3.6 12.4 37.8 16.5 21.3
Amsterdam-Maastricht (NL) 2 110 1995 10.8 9.9 17.3 26.4 19.6 6.8
Doetinchem (NL) 1 556 1995 8.7 5.0 13.0 36.4 16.9 19.5
Aarhus (DK) 6 410 1996 13.7 5.3 17.1 29.4 19.7 9.7
Copenhagen (DK) 13 839 1996 13.7 5.4 17.3 30.9 20.1 10.8
Total 36 931 1996 13.1 6.2 17.8 32.2 20.8 11.4
Women
Potsdam (D) 8 690 1996 17.6 8.6 24.4 34.4 26.9 7.5
Florence (I) 6 699 1995 11.4 9.4 17.8 27.3 20.2 7.1
Cambridge (UK) 5 921 1995 12.2 3.6 15.8 40.0 20.2 19.8
Amsterdam-Maastricht (NL) 2 570 1995 10.0 9.9 17.6 28.7 20.3 8.4
Doetinchem (NL) 1 587 1995 12.2 5.0 17.4 42.7 22.0 20.7
Aarhus (DK) 6 780 1996 12.4 5.3 14.2 20.1 15.5 4.6
Copenhagen (DK) 15 981 1996 13.1 5.4 15.0 21.9 16.5 5.4
Total 48 228 1996 13.3 6.5 17.3 27.9 19.6 8.3
aAnalysis was restricted to participants who were aged 40-65 y at recruitment.
bOne weight assessment was available for every center. Weight was directly measured on participants in light clothing in Cambridge (UK) and Doetinchem (NL) while in
the other centers weight was assessed based on self-reports.
cModel uses two points (baseline and follow-up).
dDifference was calculated from subtracting the obesity prevalence for 2015 predicted by the leveling off model from the predicted value for 2015 of the linear model.
doi:10.1371/journal.pone.0027455.t001
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(Table 2). Moreover, in most study centers the observed as well as
the predicted obesity prevalence was higher in the age group of 60-
65 years than in younger age groups.
Shape of trends in obesity prevalence (EPIC-Potsdam
data)
Subjects of the EPIC-Potsdam cohort which served as a test
population to check the linearity of the obesity trends had a mean
age of 50.2 years (quartile range: 42.4–58.0 years) and a mean
BMI of 26.1 kg/m
2 (quartile range: 23.2-28.4 kg/m
2) at baseline,
and were followed for 8.6 years on average (quartile range: 7.8–9.3
years). The prevalence of obesity amounted to 17% and 16% at
baseline and increased to 25% and 22% at the fourth follow-up for
men and women, respectively (Table 3). It appeared that among
men the increase in obesity prevalence during the last years of
follow-up was less strong than in the initial period of observation.
Thus, the log transformed model fitted the data slightly better to
the EPIC Potsdam data than a linear model among men
(Figure 3). In contrast, in women obesity prevalence increased
in a relatively linear way over 8 years of follow-up (Figure 4). In
general, the observation that obesity prevalences increases linearly
in women and more non-linearly in men was independent of age
at recruitment as this was also found in separate age groups (e.g.
40-49, 50-59, 60-65).
Discussion
In the Diogenes cohort, the prevalence of obesity increased
relatively independent of initial age in all study centers during
follow-up. If the observed trend in increase of obesity during
follow-up was linearly projected to the year 2015, an obesity
prevalence of about 30% is expected in the participants aged 40–
65 years at baseline in this cohort, which is similar to the situation
in the US nowadays. The leveling off model predicted also
considerable obesity prevalence in 2015, but with a much lower
value compared to the linear model, with a mean estimate of about
20% among person aged 40–65 years initially of the Diogenes
cohort.
The data and conclusions about observed and projected obesity
prevalences have been derived from a longitudinal study.
Conversely, publications dealing with the development of the
obesity epidemic over time are mainly based on cross-sectional
data [2,10,11,12]. However, cross-sectional data reflect only the
situation at a specific time across the age groups. For example,
they often suggest that obesity rates peak between the ages of 50 to
60 years in most developed and developing countries. Thereafter,
a drop of the rates is observed [2]. However, this drop in the
prevalence does not necessarily mean that elderly subjects loose
weight. Instead, it could be the result of birth cohort effects and
reflect the fact that older birth cohorts had not gained similar
weight with age as birth cohorts being born in a later time period.
To overcome this problem of birth cohort effects making cross-
sectional data based on one-point-in-time estimates less interpret-
able, longitudinal data are necessary: e.g. multiple sequential cross-
sectional surveys with several birth cohorts and several specific
ages or preferably prospective cohort studies. Despite this,
longitudinal data on obesity trends are rarely found in the
literature compared to cross-sectional data. Grinker et al. for
example found that obesity was strongly related to age during a
follow-up period of 15 years. The largest increase was observed
among the 30-44 year old subjects, whereas subjects aged 60 years
and older at baseline remained weight stable [19]. In our study
population we also observed a relatively strong weight increase in
young age groups. However, in contrast to Grinker et al., we could
observe an increase in weight also in the age group of 65–75 years
between the baseline and follow-up examination.
Moreover, literature about future prediction of obesity is rare
and research groups that have investigated future trends in obesity
based their projections on repeated survey data [7,8,9] [20]. These
data is based on a random sample of different individuals at each
time period; in contrast to our study that observed individuals of a
wide age range over years. However, in contrast to repeated
independent surveys, a prospective cohort is ageing during the
observation time. To consider the impact of age on future trends
in obesity prevalences, age at recruitment was included as a
covariate into the regression models. Furthermore, we stratified by
baseline age group to evaluate trends in obesity among different
age groups.
In the following we compared our study results with attempts of
other researchers to predict obesity prevalences in the future based
on repeated cross-sectional surveys. Kelly et al. projected the
global burden of obesity all over the world in 2030 [7]. Overall,
9.8% of the world’s adult population was obese in 2005 (7.7% in
men and 11.9% in women). Based on regional secular trends in
obesity prevalence estimated from past data, population growth
and demographic shifts, they predicted an increase of obesity
prevalence of up to 19.7% in 2030. However, obesity prevalences
are differing strongly between world regions. For the established
market economies which comprise developed and industrialized
high income countries the estimated prevalence of obesity in 2030
amounts to 36%. Wang et al. focused on the projection of future
trends in the United States based on repeated nationwide survey
data (National Health and Nutrition Examination Study,
NHANES) collected between 1970 and 2004 [8]. They reported
that 32.3% of the American adults were obese in 2004 and that
this proportion will increase up to 51.1% in 2030 based on the
assumption that trends will continue linearly. The projected
prevalence amounts to 37.4% in 2010 and 44.2% in 2020. These
prognoses reflect a worse situation than in Europe which is due to
considerably higher initial obesity prevalence.
To address the limitations of linear predictions based on cross-
sectional data, Wang et al. conducted a further analysis using fitted
regression models stratified by sex and race based on the
assumption that the cohort is aging 10 years to project shifts in
BMI distribution of the 1999-2000 NHANES population to 2010
[20]. These projections were also validated with data from two
longitudinal studies (Nurses’ Health Study and Health Professional
Follow-Up Study) making this approach comparable to our
analyses. The expected prevalence of obesity for 2010 was 35%
and 36% for white men and women, respectively. Zaninotto et al.
investigated different scenarios to project the prevalence of adult
obesity in England from 1993-2004 to 2012 based on repeated
cross-sectional surveys [9]. Based on the linear trend, the
prevalence of obesity among 35–74 year old individuals increased
from 15.4–17.8% (men) or 17.9-22.8% (women) in 1993 to 35.1–
36.4% for males and 30.6–35.9% for females in 2012. In contrast,
the projection based on the best fitting curve allowing to consider a
slowing down in the obesity trend lead to prevalences of 28.0–
29.8% in men and 25.8–32.0% in women in this age group. As in
our analysis, the non-linear modeling resulted in considerably
lower estimates than the linear prediction which is not surprising.
Similar to us Zaninotto et al. investigated alternatives to the linear
model. We also decided to investigate a linear and non-linear
scenario to project the situation in the near future, for the year
2015. We could show that differences in linear and non-linear
projections could be huge if the observation period was short and
the projection period long. Compared with Zaninotto et al., our
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2) for the Diogenes centers
a.
Age at
recruitment (y) n Baseline % Follow-Up %
prediction 2015: obesity
[%]
Absolute difference
between linear and
leveling off model in %
c
Linear
model
b
Leveling off
model
b
Men
Potsdam 40-49 2 549 14.7 22.7 35.8 25.9 9.9
50-59 2 765 14.4 23.7 38.8 27.4 11.4
60-65 1 376 21.5 27.8 36.1 30.0 6.1
Florence 40-49 916 9.9 17.2 28.0 19.9 8.1
50-59 868 13.0 18.4 24.3 20.1 4.2
60-65 264 16.7 21.2 26.0 22.6 3.4
Cambridge 40-49 1 122 7.6 10.6 36.1 14.6 21.5
50-59 2 016 9.8 12.7 36.4 16.5 19.9
60-65 1 140 9.8 13.5 42.2 18.3 23.9
Amsterdam-Maastricht 40-49 1 020 9.5 15.9 25.6 18.3 7.3
50-59 1 090 11.9 18.5 27.2 20.8 6.4
60-65 --- --- --- --- ---
Doetinchem 40-49 770 7.3 11.9 42.1 16.7 25.4
50-59 568 10.4 13.7 29.6 16.6 13.0
60-65 218 9.6 14.7 40.5 19.2 21.3
Aarhus 40-49 ---- --- --- --- ---
50-59 4 971 13.7 17.1 29.3 19.7 9.6
60-65 1 439 13.6 17.0 29.6 19.6 10.0
Copenhagen 40-49 --- --- --- --- ---
50-59 10 253 13.7 17.5 31.9 20.3 11.6
60-65 3 586 13.7 17.0 28.3 19.3 9.0
Women
Potsdam 40-49 3 390 12.5 19.9 32.0 22.8 9.2
50-59 3 643 18.4 25.0 34.6 27.5 7.1
60-65 1 657 26.3 32.2 40.2 34.3 5.9
Florence 40-49 1 888 6.3 13.3 26.8 16.4 10.4
50-59 3 814 13.4 19.4 27.8 21.5 6.3
60-65 997 13.4 20.3 29.0 22.6 6.4
Cambridge 40-49 1 788 9.7 12.4 29.9 15.6 14.3
50-59 2 800 12.2 16.2 45.8 21.4 24.4
60-65 1 333 15.6 19.6 43.3 24.1 19.2
Amsterdam-Maastricht 40-49 1 359 8.0 15.4 27.0 18.2 8.8
50-59 1 210 12.1 19.9 30.6 22.6 8.0
60-65 (1) --- --- --- ---
Doetinchem 40-49 824 8.0 12.4 38.2 16.6 21.6
50-59 557 17.1 22.6 45.7 27.2 18.5
60-65 206 15.5 23.3 59.7 30.4 29.3
Aarhus 40-49 --- --- --- --- ---
50-59 5 423 11.9 14.0 21.3 15.5 5.8
60-65 1 537 14.1 14.8 16.9 15.3 1.6
Copenhagen 40-49 --- --- --- --- ---
50-59 11 699 12.3 14.5 22.4 16.1 6.3
60-65 4 282 15.4 16.6 20.9 17.5 3.4
aAge stratification was used alternatively for adjustment for baseline age in the prediction models (thus only follow-up time was taken as the independent variable).
Age group of 40-49 year-old participants not present in the Danish centers. Age group of 60-65 y was not available in Amsterdam-Maastricht.
bModel uses two points (baseline and follow-up).
cDifference was calculated from subtracting the obesity prevalence for 2015 predicted by the leveling off model from the predicted value for 2015 of the linear model
doi:10.1371/journal.pone.0027455.t002
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moderate. However, our prevalence data do not represent a
specific region or country and are not representative for the total
population.
Overall, the non-linear (leveling off) approach of prediction
seems to be more realistic, whereas the linear scenario is more
likely to result in an over-estimation of future obesity prevalences.
It is likely that age-associated diseases will lead to a leveling off in
future weight gain and thus, obesity trends might slow down.
Moreover, as BMI reaches a high level, the risk for obesity-related
diseases such as diabetes mellitus type 2 or metabolic syndrome
increases considerably. Thus, severe obese subjects are forced to
control their weight because of medical reasons. Therefore, one
cannot assume that people gain weight in a linear way during their
whole life. There is also some evidence in the literature based on
repeated survey data that the trend in obesity prevalence, which
was increasing nearly linearly in the past decades, is now showing
a leveling off [21,22,23]. This fact in turn adds further support to
the leveling off approach of prediction.
Besides investigating different scenarios for future projection a
further strength of our study is the large sample size covering
cohorts from five European countries and a total of 97,942
participants. Some differences in methodologies used to collect
data on body weight might have affected the results. Therefore, we
corrected body weight for clothing differences and self-reporting
using the equations proposed by Haftenberger et al [18].
Table 3. Trends in obesity prevalence (BMI $ 30 kg/m
2) in EPIC-Potsdam.
Measurement (year)
Baseline (1994–
1998)
Follow Up 1
(1997–2001)
Follow Up 2
(1999–2003)
Follow Up 3
(2001–2005) Follow Up 4 (2004–2008)
Obesity [%] Obesity [%] Obesity [%] Obesity [%] Obesity [%]
Men (n=8 438)
EPIC-Potsdam 16.6 20.0 22.1 23.0 24.6
Application of linear model
a 17.5 (16.7–18.3)
b 19.3 (18.5–20.0) 21.1 (20.4–21.9) 23.3 (22.4–24.1) 25.1 (24.2–26.0)
Application of leveling off model
a 16.4 (15.6–17.2) 20.2 (19.4–20.9) 22.0 (21.2–22.8) 23.4 (22.5–24.2) 24.2 (23.3–25.1)
Women (n=13 791)
EPIC-Potsdam 15.8 16.9 18.4 20.5 22.2
Application of linear model
a 15.6 (15.0–16.2) 17.1 (16.5–17.7) 18.7 (18.1–19.3) 20.5 (19.9–21.1) 22.0 (21.3–22.7)
Application of leveling off model
a 15.1 (14.5–15.7) 18.0 (17.4–18.5) 19.4 (18.8–20.0) 20.4 (19.8–21.0) 21.0 (20.4–21.7)
aProbability of being obese was modeled in dependency of follow-up time and age at recruitment using logistic regression.
b95% confidence intervals are shown in parentheses and were calculated by bootstrapping.
(10 000 samples were used for men and women, respectively).
doi:10.1371/journal.pone.0027455.t003
Figure 3. Obesity trends in EPIC-Potsdam (males). _____________ = linear model using five observation points. __ __ __ __ __ = leveling off
model using five observation points.
doi:10.1371/journal.pone.0027455.g003
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because it does not take body composition, i.e. fat and lean body
mass, into account. However, several studies have shown that
even without body weight changes, the amount of body fat
significantly increases with age. That is why a BMI $ 30 kg/m
2
is associated with an excess of body fat in any case, thus being an
acceptable measure of obesity also in the elderly. Another
measure of total body fat is waist circumference, which has been
shown to be strongly related to visceral fat with a cut-off for
adults of 102 cm in men and 88 cm in women to indicate
abdominal obesity. Using these cut-offs led to a great proportion
of elderly persons (60+) having high risk values of waist
circumference [24]. However, these waist circumference cut-off
points still need to be validated as predictors of morbidity and
mortality in older ages [25].
One weakness of our study is that only two measurements of
anthropometric values were available for each subject in the
Diogenes cohort besides the cohort from Potsdam. Therefore, we
also calculated trends until 2015 in the EPIC-Potsdam dataset
where five measurements per participant were available to
investigate which of the two prediction models (linear vs. non-
linear) gives the better model fit. Furthermore, we compared
models using five data points with models using two measurements
to validate our projections. The predicted prevalence estimates for
2015 of these two different models showed a relatively good
agreement (data not shown). Thus, we can draw the conclusion
that also two observation points might be sufficient for a valid
future projection.
However, the results of this study could also be biased by several
factors such as selection bias or differential loss-to-follow-up bias.
This implies that in general those who are obese or have a poor
state of health are less likely to participate in a study for the whole
period of time [26]. Hence, our data might underestimate real
obesity prevalence trends even though already sizeable increases in
obesity prevalence during life course across all study centers were
observed. Furthermore, self-reporting of BMI can lead to under-
estimations. As already mentioned, we applied correction
equations to address this issue. Moreover, the same trends in
obesity prevalence were observed in the cohorts that have
measured data indicating that it might be valid to rely on
corrected self-reported data. A further limitation of the study is
that projections are based on a number of assumptions; some of
them were simplified scenarios e.g. that the current trend will
continue. Potential future policy-, environmental- and behavioral
changes may disprove our predictions.
Since 2015 is in the near future and the study cohort is still on
follow-up, it is possible to check whether our predictions had been
valid in a few years. This will be an excellent opportunity to
evaluate the accuracy of the linear and the leveling off model for
the prediction of future obesity prevalences. Besides verifying our
own predictions, further research is needed to investigate the
development of weight with increasing age, especially in high age
groups using a longitudinal study design.
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